EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota

Chongkai Zhai, Junhui Niu, Qinghua Qiao, Hewei Zhang, Fuchao Mao, Chengshui Liao, Zhongyu Liu

Frontiers in Microbiology · 30.07.2026 · 17

DOI: 10.3389/fmicb.2026.1881881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.07.2026. Verfasst von Chongkai Zhai und 6 weiteren Autor:innen. Beteiligte Einrichtung: The 989th Hospital of the Joint Logistics Support Force of Chinese People's Liberation Army, Luoyang, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identifying safe probiotic strains with potent antimicrobial activity is essential for the development of next-generation microbial therapeutics. Here we report a novel sapropel-derived strain, Lactiplantibacillus plantarum ( L. plantarum ) JH-N1, exhibiting antibacterial activity together with favorable probiotic traits. In vitro safety evaluation showed no mucin degradation, β-haemolytic activity or cytotoxic effects on Caco-2 cells. L. plantarum JH-N1 displayed marked tolerance to simulated gastrointestinal stress, surviving exposure to pH 2 and bile salts, and showed strong cell-surface hydrophobicity, auto-aggregation and co-aggregation with multiple pathogens. The strain also adhered efficiently to Caco-2 cells and remained susceptible to most clinically relevant antibiotics. In vivo , acute and subacute toxicity studies in mice revealed no adverse effects on body weight, organ indices, tissue histology, hematological parameters or serum biochemical markers. Notably, L. plantarum JH-N1 improved intestinal morphology by promoting villus development and increasing crypt depth in multiple gut segments. Moreover, administration of L. plantarum JH-N1 reshaped the gut microbiota, increasing beneficial bacterial populations while reducing potentially harmful taxa. Together, these findings identify L. plantarum JH-N1 as a safe and functionally robust probiotic candidate with promise for animal husbandry and biomedical applications.

Schlagwörter

Stichwörter der Autor:innen

Lactiplantibacillus plantarumantimicrobial activitybiosafetyprobioticsapropel

Autor:innen und Institutionen

  • The 989th Hospital of the Joint Logistics Support Force of Chinese People's Liberation Army, Luoyang, China.
  • College of Food and Drugs, Luoyang Polytechnic, Luoyang, China.
  • Animal Diseases and Public Health Engineering Research Center of Henan Province, Luoyang, China.
  • The Geographical Indication Medicines and Life Health Engineering Research Center of Henan Province, Luoyang, China.
  • College of Animal Science and Technology/Laboratory of Functional Microbiology and Animal Health, Henan University of Science and Technology, Luoyang, China.

Zitieren

APA

Zhai, C., Niu, J., Qiao, Q., Zhang, H., Mao, F., Liao, C., & Liu, Z. (2026). A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1881881

Vancouver

Zhai C, Niu J, Qiao Q, Zhang H, Mao F, Liao C, et al. A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1881881

BibTeX
@article{Zhai2026,
  author = {Zhai, Chongkai and Niu, Junhui and Qiao, Qinghua and Zhang, Hewei and Mao, Fuchao and Liao, Chengshui and Liu, Zhongyu},
  title = {A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1881881}
}
Kostenlos starten →